Acarix A/S

ACARIX · Nasdaq Stockholm · Healthcare

0.21SEK −0.9%last day

Price as of 2 October 2026

The price over the past year, with dividends: −30.5%

Performance

1 month

−10.5%

1 year

−30.5%

3 years, per year

−0.1%

5 years, per year

−26.8%

Largest fall, 3 years

−88.7%

Below the peak now

−98.1%

Volatility, 1 year

43.5%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

5.6

Dividend yield

0.0%

Return on equity

−90.0%

Net margin

–

Market value

25 m USD

Quality, value and trend

Where Acarix stands against every Nordic stock today. 100 is best.

Quality79

Profitability and a sound balance sheet over time. Better than 79% of Nordic stocks.

Value4

The price measured against earnings, assets and cash flow. Better than 4% of Nordic stocks.

Trend12

The price development over the past year. Better than 12% of Nordic stocks.

Combined16

Quality, value and trend together. Better than 16% of Nordic stocks.

About Acarix

Acarix A/S is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 8 employees.

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis